http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000513324-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-549 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-549 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12 |
filingDate | 1996-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2000-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2000513324-A |
titleOfInvention | Compositions and methods for treating bone defect conditions |
abstract | (57) [Summary]nA compound comprising two aromatic systems covalently linked via a linker containing one or more atoms, or as defined to include itself covalently linked through an aromatic system at a distance of 1.5-15 ° "Linkers" are effective in treating conditions involving bone defects. The compound can be administered to a vertebrate subject alone or in combination with an additional agent that promotes bone growth or inhibits bone resorption. They assess their ability to affect the transcription of a reporter gene linked to a promoter associated with bone morphogenetic proteins and / or stimulate calvarial growth in model animal systems prior to administration Are screened for activity. |
priorityDate | 1995-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 468.